VIRTUAL 2021

The 37th Annual Meeting of the Histiocyte Society was held virtually this year. 

General Meeting Agenda (subject to change):

Monday, October 11, 2021 from 11:00am-3:00pm Eastern Time (US) - Times listed below are Eastern Time:

1100 - 1115           Opening Ceremonies: Histiocyte Society President, Michael Jordan; special welcome by Paul Kontoyannis
1115 - 1200           Guest Speaker Presentation: Florent Ginhoux
           "Senescent Langerhans cell histiocytosis cells arise from both dendritic cell (DC) and monocyte/DC3 lineages"
1200 - 1230          Clinical Studies and Registries Update
1230 - 1245        Oral Presentations
Abstract Presentation #1 - Fabrizio De Benedetti
     MACROPHAGE ACTIVATION SYNDROME (MAS) IN SYSTEMIC JUVENILE IDIOPATHIS ARTHRITIS (SJIA): TREATMENT WITH EMAPALUMAB, AN ANTI-INTERFERON GAMMA (IFNγ) ANTIBODY 

Abstract Presentation #2 - Jan-Inge Henter
RESPONSE TO MAP INHIBITION OF NEURODEGENERATION IN LCH MONITORED BY CSF NEUROFILAMENT LIGHT AS A BIOMARKER
1245 - 1300          Break
1300 - 1430          Poster Presentation Session
1430 - 1530+        Virtual Welcome reception via Spatial Chat platform        


Tuesday, October 12, 2021 from 11:00am-3:00pm Eastern Time (US) - Times listed below are Eastern Time:

1100 - 1145           Guest Speaker Presentation: Jana Pachlopnik-Schmid
          "Hemophagocytic lymphohistiocytosis"
1145 - 1315           Abstract presentation Session: Presidential Symposium
      Abstracts nominated for the Nesbit Award in Clinical Science:

THE INTERIM RESULTS OF A MULTICENTER STUDY OF SAFETY AND EFFICACY OF VEMURAFENIB AND CYTARBINE PLUS CLADRIBINE THERAPY IN HIGH-RISK PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS WITH BRAF V600E MUTATION - Dmitry Evseev

PERI-TRANSPLANT ALEMTUZUMAB LEVELS PREDICT RISK OF SECONDARY GRAFT FAILURE AND INVERSELY IMPACT CXCL9 LEVELS AFTER RIC-HCT (A CORRELATIVE BIOLOGY STUDY TO BMT-CTN 1204 RICHI)- Ashley Geerlinks

ALK+ HISTIOCYTOSIS: A NEW CLINICOPATHOLOGIC SPECTRUM HIGHLIGHTING NEUROLOGIC INVOLVEMENT AND RESPONSES TO ALK INHIBITION - Paul Kemps

      Abstracts nominate for the Nezelof Award in Basic Science:

CYTOTOXIC IMPAIRMENT AND EXCESS IL-18 DRIVE SPONTANEOUS, OLIGOCLONAL CD8 T-CELL HYPERACTIVATION AND HYPERINFLAMMATORY DISEASE- Emily Landy

LINEAGE-SWITCH OF CELLS HARBORING BRAF V600E ALLELES IN PATIENTS WITH HIGH RISK LCH TREATED WITH INHIBITORS - Paul Milne

BRAF-V600E EXPRESSION IN DENDRITIC CELLS REPROGRAMS TRANSLATIONAL DYNAMICS TO INCREASE LPS-INDUCED TNFA PRODUCTION - Danielle Minichino
1315 - 1330       Break    
1330 - 1430           General Assembly Business Meeting*
1430 - 1530+         Histiocyte Society ‘Virtual Banquet’ via Spatial Chat and Closing Ceremonies           
      Awarding of Scientific Prizes

   

Check back often for the most up to date information.

Registrants will be invited to the virtual platform on or around October 4, 2021.

The abstract submission deadline has now passed.  Thank you for all of your submissions.
Authors have been notified of their status.

About the Society

The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

Copyright © 2020 Histiocyte Society

Contact

secretariat@histiocytesociety.org
Phone: +1 856 589 6606 
Fax: +1 856 589 6614
332 N Broadway
Pitman, NJ 08071 USA

Powered by Wild Apricot Membership Software